Acute Patella Tendon Rupture Clinical Trial
Official title:
Surgical Treatment for Acute Patella Tendon Rupture: a Prospective, Randomized Study Comparing Transpatellar Suture Tunnels Method vs. Suture Anchors.
Verified date | September 2013 |
Source | Emory University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
We will compare two groups for acute patella tendon repair: one treated with surgical anchors and the second, with transpatellar tunnels.
Status | Terminated |
Enrollment | 3 |
Est. completion date | December 2009 |
Est. primary completion date | December 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Stage of Disease: Acute ruptures of the patella tendon, no more than 3 weeks since the time of injury. 2. Age: 18 years old and up. 3. Performance status: Patients with no other previous illnesses that prevented them to ambulate normally (without help of devices). 4. Informed consent requirements: One person from our research staff will approach the patient after the diagnosis has been made. The diagnosis will be made by the doctor in charge on the patient care based on the medical history, physical exam and image studies (MRI). We will explain the benefits/risks to be part of the study and that they are not obligated to be part of it as part of their care. Exclusion Criteria: 1. Prior treatment: Patients with chronic patella tendon ruptures (more than 3 weeks). 2. Prior other diseases: diseases with systemic collagen deficiencies. 3. Infection: Patients with active infection will be disqualified. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Grady Healthcare System | Atlanta | Georgia |
Lead Sponsor | Collaborator |
---|---|
Emory University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Outcome measures will include SF 36, Tegner and Lysholm scores, as well as IKDC scores. | Weeks 0-3, 4-6, 7-8, 12 and 16-24 after surgery: | Yes |